Fmoc-L-HoLeu-OH

Fmoc-L-HoLeu-OH is an Fmoc-protected L-amino acid derivative in which the side chain is built on a hydroxy-oleucine (HoLeu) framework, providing both a stereodefined α-amino acid core and a functional hydroxyl group for downstream chemistry. The Fmoc carbamate masks the α-amine to enable controlled peptide coupling while maintaining compatibility with standard base-mediated deprotection workflows used in solid-phase synthesis. The free carboxylic acid enables C-terminal activation for amide bond formation, whereas the side-chain hydroxyl can participate in hydrogen bonding, influence conformational preferences, and serve as a handle for selective protection, derivatization, or further functional group interconversion. The presence of a stereogenic center at the α-position supports stereochemically consistent incorporation into peptide sequences and chiral intermediate preparation for medicinal chemistry and biochemical research.

1. Peptide Synthesis

Fmoc-L-HoLeu-OH supports peptide building-block preparation for both automated and manual peptide synthesis workflows where Fmoc-based N-protection is required. The Fmoc-protected α-amine and the free carboxylic acid enable stepwise peptide coupling to form amide linkages while the HoLeu side-chain hydroxyl can be managed through orthogonal protection strategies when selective side-chain chemistry is needed. Side-chain hydroxyl functionality can be retained for incorporation into peptide analogs that require hydrogen-bonding interactions or can be temporarily protected to prevent undesired reactions during chain assembly. Downstream peptide products can be used as research reagents for mapping sequence-dependent properties and for generating protected or functionalized peptide fragments for further synthetic elaboration.

2. Side-Chain Functionalization

Fmoc-L-HoLeu-OH enables amino acid derivatization strategies that leverage the side-chain hydroxyl for controlled chemical modification. The hydroxyl group can be converted into activated esters, ethers, or other oxygen-based substituents under conditions that preserve the stereodefined α-center, allowing access to hydroxyl-bearing peptidomimetics and structure-tunable analogs. Fmoc protection allows the amino group to remain masked during side-chain derivatization, supporting sequential synthetic logic in which side-chain chemistry and backbone coupling are decoupled. The resulting functionalized derivatives can serve as intermediates for conjugation chemistry, receptor/biomolecule binding studies, and synthetic organic routes that require stereochemically defined amino acid fragments.

3. Chemical Biology Probes

Fmoc-L-HoLeu-OH can be applied to chemical biology research where hydroxyl-functional amino acid residues are used to modulate polarity, hydrogen-bonding networks, and recognition in peptide-based probes. The Fmoc-protected amino acid format facilitates incorporation into peptide tags, affinity handles, or labeled peptide scaffolds using peptide coupling chemistry that preserves the HoLeu stereochemistry. The side-chain hydroxyl provides a functional handle for post-synthetic modification, including attachment of linkers or transformation into conjugation-ready groups without disrupting the peptide backbone. Labeled or modified peptide constructs derived from Fmoc-L-HoLeu-OH can be utilized for biomolecular interaction studies, target engagement mapping, and mechanistic investigations that rely on controlled chemical functionality.

4. Peptidomimetics And SAR

Fmoc-L-HoLeu-OH serves as a chiral amino acid intermediate for peptidomimetic construction and structure-activity relationship studies that require hydroxyl-bearing stereodefined residues. The α-amino acid backbone supports incorporation into constrained analogs, while the side-chain hydroxyl can be used to tune solubility, intramolecular hydrogen bonding, and conformational bias in peptide-like scaffolds. Fmoc-based synthesis compatibility enables systematic generation of analog series where the HoLeu residue is varied alongside other protected amino acids, supporting SAR workflows that depend on consistent stereochemical placement. The compound's functional group pattern supports downstream conversion into additional oxygenated motifs, enabling iterative medicinal chemistry exploration through amino acid derivatization and peptide analog assembly.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-HoLeu-OH is suitable for process chemistry intermediate preparation in manufacturing contexts that require protected amino acid building blocks for downstream peptide and peptidomimetic synthesis. The Fmoc carbamate provides a robust N-protection strategy that can be removed under controlled conditions to expose the amino functionality for coupling, while the carboxylic acid supports reliable activation chemistry in amide bond formation. The stereodefined L-configuration and the hydroxyl side chain allow the compound to function as a defined chiral fragment for producing hydroxyl-containing intermediates used in fine chemical synthesis. Downstream utilization can include preparation of peptide fragments, activated derivatives, or protected intermediates that feed into larger-scale synthetic sequences for pharmaceutical research materials and specialty chemical production.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. The spatiotemporal control of signalling and trafficking of the GLP-1R